Advances in treatment of Vogt-Koyanagi-Harada syndrome / 国际眼科杂志(Guoji Yanke Zazhi)
International Eye Science
; (12): 1082-1086, 2017.
Article
em Zh
| WPRIM
| ID: wpr-641218
Biblioteca responsável:
WPRO
ABSTRACT
Vogt-Koyanagi-Harada (VKH)syndrome is an autoimmune disease attacking against pigmented cells, resulting in blindness and usually affecting multiple organs including ears, meninges, hair and skin.Correct diagnosis and immediate treatment in the early stage is vital to visual prognosis.Currently, corticosteroids is first-line drug.In addition, VKH patients refractory to corticosteroids can choose other treatment such as immunosuppressive agents and biological agents.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
International Eye Science
Ano de publicação:
2017
Tipo de documento:
Article